China · Delayed Price · Currency is CNY Baolingbao Biology Statistics
Total Valuation
SHE:002286 has a market cap or net worth of CNY 3.21 billion. The enterprise value is 3.08 billion.
| Market Cap | 3.21B |
| Enterprise Value | 3.08B |
Important Dates
The last earnings date was Thursday, August 27, 2026.
| Earnings Date | Aug 27, 2026 |
| Ex-Dividend Date | Jul 14, 2026 |
Share Statistics
SHE:002286 has 380.57 million shares outstanding. The number of shares has decreased by -1.15% in one year.
| Current Share Class | 380.57M |
| Shares Outstanding | 380.57M |
| Shares Change (YoY) | -1.15% |
| Shares Change (QoQ) | -6.46% |
| Owned by Insiders (%) | 9.18% |
| Owned by Institutions (%) | 6.43% |
| Float | 278.40M |
Valuation Ratios
The trailing PE ratio is 22.21 and the forward PE ratio is 15.92.
| PE Ratio | 22.21 |
| Forward PE | 15.92 |
| PS Ratio | 1.13 |
| PB Ratio | 1.38 |
| P/TBV Ratio | 1.45 |
| P/FCF Ratio | 28.69 |
| P/OCF Ratio | 9.05 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.56, with an EV/FCF ratio of 27.48.
| EV / Earnings | 21.93 |
| EV / Sales | 1.08 |
| EV / EBITDA | 10.56 |
| EV / EBIT | 18.13 |
| EV / FCF | 27.48 |
Financial Position
The company has a current ratio of 1.74, with a Debt / Equity ratio of 0.08.
| Current Ratio | 1.74 |
| Quick Ratio | 1.12 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 0.60 |
| Debt / FCF | 1.58 |
| Interest Coverage | 18.85 |
Financial Efficiency
Return on equity (ROE) is 6.31% and return on invested capital (ROIC) is 6.46%.
| Return on Equity (ROE) | 6.31% |
| Return on Assets (ROA) | 3.70% |
| Return on Invested Capital (ROIC) | 6.46% |
| Return on Capital Employed (ROCE) | 7.08% |
| Weighted Average Cost of Capital (WACC) | 7.32% |
| Revenue Per Employee | 1.89M |
| Profits Per Employee | 93,206 |
| Employee Count | 1,505 |
| Asset Turnover | 0.98 |
| Inventory Turnover | 7.40 |
Taxes
In the past 12 months, SHE:002286 has paid 27.83 million in taxes.
| Income Tax | 27.83M |
| Effective Tax Rate | 16.56% |
Stock Price Statistics
The stock price has decreased by -27.62% in the last 52 weeks. The beta is 0.59, so SHE:002286's price volatility has been lower than the market average.
| Beta (5Y) | 0.59 |
| 52-Week Price Change | -27.62% |
| 50-Day Moving Average | 8.07 |
| 200-Day Moving Average | 9.32 |
| Relative Strength Index (RSI) | 58.05 |
| Average Volume (20 Days) | 9,949,799 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:002286 had revenue of CNY 2.85 billion and earned 140.28 million in profits. Earnings per share was 0.38.
| Revenue | 2.85B |
| Gross Profit | 396.22M |
| Operating Income | 171.80M |
| Pretax Income | 168.11M |
| Net Income | 140.28M |
| EBITDA | 290.38M |
| EBIT | 171.80M |
| Earnings Per Share (EPS) | 0.38 |
Balance Sheet
The company has 312.80 million in cash and 177.35 million in debt, with a net cash position of 135.45 million or 0.36 per share.
| Cash & Cash Equivalents | 312.80M |
| Total Debt | 177.35M |
| Net Cash | 135.45M |
| Net Cash Per Share | 0.36 |
| Equity (Book Value) | 2.33B |
| Book Value Per Share | 6.43 |
| Working Capital | 444.01M |
Cash Flow
In the last 12 months, operating cash flow was 354.81 million and capital expenditures -242.84 million, giving a free cash flow of 111.96 million.
| Operating Cash Flow | 354.81M |
| Capital Expenditures | -242.84M |
| Depreciation & Amortization | 118.57M |
| Net Borrowing | -131.49M |
| Free Cash Flow | 111.96M |
| FCF Per Share | 0.29 |
Margins
Gross margin is 13.91%, with operating and profit margins of 6.03% and 4.93%.
| Gross Margin | 13.91% |
| Operating Margin | 6.03% |
| Pretax Margin | 5.90% |
| Profit Margin | 4.93% |
| EBITDA Margin | 10.20% |
| EBIT Margin | 6.03% |
| FCF Margin | 3.93% |
Dividends & Yields
This stock pays an annual dividend of 0.12, which amounts to a dividend yield of 1.50%.
| Dividend Per Share | 0.12 |
| Dividend Yield | 1.50% |
| Dividend Growth (YoY) | 26.32% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 5.00% |
| Buyback Yield | 1.15% |
| Shareholder Yield | 2.65% |
| Earnings Yield | 4.37% |
| FCF Yield | 3.49% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 9, 2014. It was a forward split with a ratio of 2.
| Last Split Date | Jun 9, 2014 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |